These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1445914)

  • 1. An investigation of the sequence-specific interaction of cis-diamminedichloroplatinum(II) and four analogues, including two acridine-tethered complexes, with DNA inside human cells.
    Murray V; Motyka H; England PR; Wickham G; Lee HH; Denny WA; McFadyen WD
    Biochemistry; 1992 Dec; 31(47):11812-7. PubMed ID: 1445914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of DNA-targeted 9-aminoacridine-4-carboxamide platinum complexes with DNA in intact human cells.
    Temple MD; Recabarren P; McFadyen WD; Holmes RJ; Denny WA; Murray V
    Biochim Biophys Acta; 2002 Apr; 1574(3):223-30. PubMed ID: 11997087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Taq DNA polymerase to determine the sequence specificity of DNA damage caused by cis-diamminedichloroplatinum(II), acridine-tethered platinum(II) diammine complexes or two analogues.
    Murray V; Motyka H; England PR; Wickham G; Lee HH; Denny WA; McFadyen WD
    J Biol Chem; 1992 Sep; 267(26):18805-9. PubMed ID: 1527009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of 11 cisplatin analogues with DNA: characteristic pattern of damage with monofunctional analogues.
    Murray V; Whittaker J; Temple MD; McFadyen WD
    Biochim Biophys Acta; 1997 Nov; 1354(3):261-71. PubMed ID: 9427535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequence selectivity of cisplatin analogues in intact human cells.
    Murray V; Whittaker J; McFadyen WD
    Chem Biol Interact; 1998 Mar; 110(1-2):27-37. PubMed ID: 9566723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
    Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
    Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
    Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of cisplatin and analogues with DNA in reconstituted chromatin.
    Galea AM; Murray V
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):142-52. PubMed ID: 12427549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of DNA-targeted platinum phenanthridinium complexes with DNA.
    Whittaker J; McFadyen WD; Wickham G; Wakelin LP; Murray V
    Nucleic Acids Res; 1998 Sep; 26(17):3933-9. PubMed ID: 9705500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II).
    Lee HH; Palmer BD; Baguley BC; Chin M; McFadyen WD; Wickham G; Thorsbourne-Palmer D; Wakelin LP; Denny WA
    J Med Chem; 1992 Aug; 35(16):2983-7. PubMed ID: 1501223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the sequence specificity of cis-diamminedichloroplatinum (II) damage in guanine- and 7-deazaguanine-containing DNA.
    Cairns MJ; Murray V
    Biochim Biophys Acta; 1994 Aug; 1218(3):315-21. PubMed ID: 8049257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
    Heiger-Bernays WJ; Essigmann JM; Lippard SJ
    Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
    Knox RJ; Friedlos F; Lydall DA; Roberts JJ
    Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex.
    Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V
    Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase.
    Ponti M; Forrow SM; Souhami RL; D'Incalci M; Hartley JA
    Nucleic Acids Res; 1991 Jun; 19(11):2929-33. PubMed ID: 2057351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
    Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
    Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of peptide-tethered platinum(II) complexes with DNA.
    Robillard MS; Davies NP; van der Marel GA; van Boom JH; Reedijk J; Murray V
    J Inorg Biochem; 2003 Aug; 96(2-3):331-8. PubMed ID: 12888268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of DNA strand breaks in Escherichia coli treated with platinum(IV) antitumor compounds.
    Defais M; Germanier M; Johnson NP
    Chem Biol Interact; 1990; 74(3):343-52. PubMed ID: 2112045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
    Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
    Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.